Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal ...

Now that we live in a connected world, tracking your car’s location has never been easier. Using GPS technology, affor ...

As global markets face challenges such as trade uncertainties and inflation concerns, Asian markets have shown resilience with modest gains in Japan and stimulus-driven optimism in China. In this ...

WILMINGTON, DE — NiKang Therapeutics® Inc. has achieved a pivotal step in the development of its first-in-class CDK2 degrader ...